Low recurrence rates for challenging squamous cell carcinomas using Mohs micrographic surgery with AE1/AE3 cytokeratin immunostaining - 10/04/21

Leora Aizman, BS ^{a, ⁎} , Christopher J. Miller, MD ^b, Allison M. Perz, BS ^c, Tess M. Lukowiak, BS ^d, Olivia G. Cohen, BS, MS ^e, Eric Bean, BS ^e, Michaela K. Hitchner, BS ^e, Jeremy R. Etzkorn, MD, MS ^b, Thuzar M. Shin, MD, PhD ^b, H. William Higgins, MD ^b, Cerrene N. Giordano, MD ^b, Justine V. Cohen, MD ^e, John T. Miura, MD ^f, Joseph F. Sobanko, MD ^b

^a George Washington University School of Medicine and Health Sciences, Washington, District of Columbia 

^b Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia 

^c Cooper Medical School of Rowan University, Camden, New Jersey 

^d Drexel University College of Medicine, Philadelphia, Pennsylvania 

^e University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 

^f Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 

^∗Correspondence to: Leora Aizman, BS, George Washington University School of Medicine and Health Sciences, 2300 I St NW, Washington, DC 20052George Washington University School of Medicine and Health Sciences2300 I St NWWashingtonDC20052